Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Rabbitpox: a model of airborne transmission of smallpox.

Nalca A, Nichols DK.

J Gen Virol. 2011 Jan;92(Pt 1):31-5. doi: 10.1099/vir.0.026237-0. Epub 2010 Oct 21. Review.

PMID:
20965981
2.

Animal models of orthopoxvirus infection.

Chapman JL, Nichols DK, Martinez MJ, Raymond JW.

Vet Pathol. 2010 Sep;47(5):852-70. doi: 10.1177/0300985810378649. Epub 2010 Aug 3. Review.

PMID:
20682806
3.

Mouse models for studying orthopoxvirus respiratory infections.

Schriewer J, Buller RM, Owens G.

Methods Mol Biol. 2004;269:289-308. Review.

PMID:
15114022
4.

Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.

Meseda CA, Weir JP.

Future Microbiol. 2010 Sep;5(9):1367-82. doi: 10.2217/fmb.10.98. Review.

PMID:
20860482
5.

Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.

Rice AD, Adams MM, Wallace G, Burrage AM, Lindsey SF, Smith AJ, Swetnam D, Manning BR, Gray SA, Lampert B, Foster S, Lanier R, Robertson A, Painter G, Moyer RW.

Viruses. 2011 Jan;3(1):47-62. doi: 10.3390/v3010047. Review.

6.

Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.

Rice AD, Adams MM, Lampert B, Foster S, Robertson A, Painter G, Moyer RW.

Viruses. 2011 Feb;3(2):63-82. doi: 10.3390/v3020063. Review.

7.

Smallpox vaccines: Past, present, and future.

Parrino J, Graham BS.

J Allergy Clin Immunol. 2006 Dec;118(6):1320-6. Review.

PMID:
17157663
8.

Correlates of protective immunity in poxvirus infection: where does antibody stand?

Panchanathan V, Chaudhri G, Karupiah G.

Immunol Cell Biol. 2008 Jan;86(1):80-6. Epub 2007 Oct 9. Review.

PMID:
17923850
9.

Immune response to poxvirus infections in various animals.

Smith SA, Kotwal GJ.

Crit Rev Microbiol. 2002;28(3):149-85. Review.

PMID:
12385498
10.

Countermeasures to the bioterrorist threat of smallpox.

Jahrling PB, Fritz EA, Hensley LE.

Curr Mol Med. 2005 Dec;5(8):817-26. Review.

PMID:
16375715
11.

The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Keckler MS, Reynolds MG, Damon IK, Karem KL.

Vaccine. 2013 Oct 25;31(45):5192-201. doi: 10.1016/j.vaccine.2013.08.039. Epub 2013 Aug 27. Review.

12.

Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization.

Niemiałtowski MG, Toka FN, Malicka E, Gieryńska, Spohr de Faundez I, Schollenberger A.

Arch Immunol Ther Exp (Warsz). 1996;44(5-6):373-8. Review.

PMID:
9017154
13.

Smallpox vaccines for biodefense: need and feasibility.

Artenstein AW, Grabenstein JD.

Expert Rev Vaccines. 2008 Oct;7(8):1225-37. doi: 10.1586/14760584.7.8.1225. Review.

PMID:
18844596
14.

Adventures with poxviruses of vertebrates.

Fenner F.

FEMS Microbiol Rev. 2000 Apr;24(2):123-33. Review.

15.

Smallpox antiviral drug development: satisfying the animal efficacy rule.

Jordan R, Hruby D.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):277-89. Review.

PMID:
16597208
16.

The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.

Handley L, Buller RM, Frey SE, Bellone C, Parker S.

Expert Rev Vaccines. 2009 Jul;8(7):841-50. doi: 10.1586/erv.09.55. Review.

PMID:
19538111
17.

What was the primary mode of smallpox transmission? Implications for biodefense.

Milton DK.

Front Cell Infect Microbiol. 2012 Nov 29;2:150. doi: 10.3389/fcimb.2012.00150. eCollection 2012. Review.

18.

Smallpox: a review of clinical disease and vaccination.

Lofquist JM, Weimert NA, Hayney MS.

Am J Health Syst Pharm. 2003 Apr 15;60(8):749-56; quiz 757-8. Review.

PMID:
12749161
19.

Zoonotic poxvirus infections in humans.

Lewis-Jones S.

Curr Opin Infect Dis. 2004 Apr;17(2):81-9. Review.

PMID:
15021045
20.

Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDS.

Esteban M.

Hum Vaccin. 2009 Dec;5(12):867-71. Epub 2009 Dec 3. Review.

PMID:
19786840

Supplemental Content

Support Center